A Finnish population study shows that signs related to Alzheimer's disease may already be found in the brain in middle age.

Some forgetfulness is part of the aging process. Recognizing when it could be something more can help families cope with a ...

Illimis Therapeutics’ Series B round was led by Korean venture capital firm DSC Investment. Seoul-based Illimis Therapeutics has raised 58 billion won ($42 million) to fund its research into ...

A medical breakthrough could soon change how we diagnose one of the most devastating brain diseases of our time. On Bloom, I ...

Previous studies have concluded that early intervention in dementia cases can increase patients' treatment options and ...

Approval was based on results from the Phase IIIb TRAILBLAZER-ALZ 6 trial, which showed that Kisunla achieved comparable ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

A pen, paper, and 30 seconds might be all it takes to uncover if you are struggling with early dementia signs, as Fiona ...

Neurons that die early in Alzheimer’s help drive brain waste removal. Treating this process sooner could change outcomes.

The benefit-risk balance is tipping more in favor of Eli Lilly’s Kisunla in early Alzheimer’s disease as the FDA ...

Living with Alzheimer’s disease can be both challenging and frightening. However, stories of resilience and hope can inspire ...

A Finnish population study shows that signs related to Alzheimer's disease may already be found in the brain in middle age.